| 000 | 01875cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030618.0 | ||
| 008 | 120505s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.04.Ph.D.2012.Am.E | ||
| 100 | 0 | _aAmgad Ahmed Shaheen | |
| 245 | 1 | 0 |
_aEvaluation of vascular endothelial growth factor as prognostic marker in inoperable hepatocellular carcinoma / _cAmgad Ahmed Shaheen ; Supervised Heba Mohamed Elzawahry , Nadia Zakhary , Reda Hassan Tabashy |
| 246 | 1 | 5 | _aتقييم مستوى معامل النمو للخلايا المبطنة للاوعية الدموية كعامل استدلالى فى حالات سرطان الكبد المتقدمة |
| 260 |
_aCairo : _bAmgad Ahmed Shaheen , _c2012 |
||
| 300 |
_a140 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-medical | ||
| 520 | _aHCC is one of the most common malignant tumors worlwide . The difficulties in treating HCC and the high mortality rate associated with it are attributable to cirrhosis which is not only a cause of morbidity but also limits treatment options for the cancer . HCC is usually asymptomatic at early stages and has a great propensity for intra - vascular or intra biliary extension even when primary tumor is small | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aInoperable hepatocellular carcinoma | |
| 653 | 4 | _aPrognostic marker | |
| 653 | 4 | _aVascular endothelial growth factor | |
| 700 | 0 |
_aHeba Mohamed Elzawahry , _eSupervisor |
|
| 700 | 0 |
_aNadia Zakhary , _eSupervisor |
|
| 700 | 0 |
_aReda Hassan Tabashy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c38348 _d38348 |
||